Acupuncture for Pain Control After Elective Caesarean Section
ACUSEC
Acupuncture vs. Placebo Acupuncture and vs. Standard Therapy for Pain Control After Elective Caesarean Section - a Randomized Controlled Trial
1 other identifier
interventional
180
1 country
1
Brief Summary
The study entitled "Acupuncture vs. placebo acupuncture and vs. standard therapy for pain control after elective caesarian section - a randomized controlled trial" aims to investigate whether acupuncture with indwelling fixed needles reduces pain and analgesic requirement as compared to placebo and standard therapy in patients after after elective caesarian section (CS) in the period from January 2015 to May 2016. For that purpose 180 adult patients scheduled to elective elective CS in spinal anesthesia will be recruited according to eligibility criteria. 120 patients will be randomized either to verum or placebo acupuncture, 60 patients will be included in non-randomized "standard therapy" arm. The outcome measures are: postoperative analgesic requirement, pain intensity, incidence of side effects and physiological parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 postoperative-pain
Started Jan 2015
Longer than P75 for phase_2 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2015
CompletedFirst Submitted
Initial submission to the registry
February 9, 2015
CompletedFirst Posted
Study publicly available on registry
February 16, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 27, 2018
CompletedJanuary 11, 2021
January 1, 2021
3.5 years
February 9, 2015
January 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Pain intensity as measured by Numeric Rating Scale 1-10
4:00 P.M. on the 1st postoperative day
Secondary Outcomes (2)
Total requirement of postoperative analgesics
4:00 P.M. on the 2nd postoperative day
Incidence of complications and adverse effects
4:00 P.M. on the 2nd postoperative day
Study Arms (3)
Verum acupuncture
EXPERIMENTALEach patient will receive 16 permanent indwelling acupuncture needles, embedded in adhesive tape, bilaterally in addition to standard postoperative analgesia
Placebo acupuncture
PLACEBO COMPARATOREach patient will receive 16 adhesive tapes mimicking the indwelling acupuncture needles bilaterally in addition to standard postoperative analgesia
Standard therapy
ACTIVE COMPARATOREach patient will receive just standard postoperative analgesia
Interventions
Standard therapy includes pharmacologic treatment of postoperative pain according to the standards of our University hospital
Verum acupuncture will be performed using indwelling permanent acupuncture needles "New Pyonex" with 1,5 mm length, manufactured by Seirin Corp. Japan
Placebo acupuncture will be performed using the placebo "New Pyonex" adhesive tapes, mimicking the needles, manufactured by Seirin Corp. Japan
Eligibility Criteria
You may qualify if:
- Patients with an American Society of Anaesthesiologists physical status of I to III scheduled for elective caesarean section in spinal anaesthesia
- Surgery time does not exceed 60 minutes
- Patients without previous opioid and psychotropic medication
- Patients ranged 19-45 years old
- Patients who have given written informed consent
You may not qualify if:
- Recidivist alcoholics
- Local skin infection at the sites of acupuncture
- Age \< 19 and \> 45 years
- Switching to general anaesthesia in cases where spinal anaesthesia fails
- Surgery time more than 60 minutes
- Intraoperative complications (bleeding, required blood transfusion more than 6 units of packed cells, cardiovascular instability, required catecholamines except for short hypotension after induction of spinal anaesthesia )
- Patients who consumed opioid medication at least 6 months before surgery
- Patients who are unable to understand the consent form and fill in the study questionnaire
- History of psychiatric disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ernst Moritz Arndt University
Greifswald, 17475, Germany
Related Publications (3)
Usichenko TI. Acupuncture as part of multimodal analgesia after caesarean section. Acupunct Med. 2014 Jun;32(3):297-8. doi: 10.1136/acupmed-2014-010584. Epub 2014 May 7. No abstract available.
PMID: 24809368BACKGROUNDUsichenko TI, Henkel BJ, Klausenitz C, Hesse T, Pierdant G, Cummings M, Hahnenkamp K. Effectiveness of Acupuncture for Pain Control After Cesarean Delivery: A Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e220517. doi: 10.1001/jamanetworkopen.2022.0517.
PMID: 35226080DERIVEDZimpel SA, Torloni MR, Porfirio GJ, Flumignan RL, da Silva EM. Complementary and alternative therapies for post-caesarean pain. Cochrane Database Syst Rev. 2020 Sep 1;9(9):CD011216. doi: 10.1002/14651858.CD011216.pub2.
PMID: 32871021DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Taras I Usichenko, MD, PhD
University Medicine of Greifswald
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2015
First Posted
February 16, 2015
Study Start
January 13, 2015
Primary Completion
June 27, 2018
Study Completion
June 27, 2018
Last Updated
January 11, 2021
Record last verified: 2021-01